Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Avricore Health Inc. (AVCRF)
OTHER OTC:AVCRF
Holding AVCRF?
Track your performance easily
AVCRF Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.03 - $0.25
Previous CloseN/A
Volume61.00K
Average Volume (3M)19.03K
Market Cap
$4.55M
Enterprise Value$17.28M
Total Cash (Recent Filing)$427.48K
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)55.0
Beta0.21
Next Earnings
May 06, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding101,289,665
10 Day Avg. Volume13,103
30 Day Avg. Volume19,034
Standard Deviation0.55
R-Squared0.02
Alpha0.11
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.40
Price to Cash Flow (P/CF)6.80
P/FCF Ratio9.50
Enterprise Value/Market Cap3.79
Enterprise Value/Revenue3.66
Enterprise Value/Gross Profit14.36
Enterprise Value/Ebitda9.04
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Avricore Health News
PremiumCompany Announcements
Avricore Health Shines in Deloitte’s Fast 50 Ranking
PremiumCompany Announcements
Avricore Health Reports Revenue Surge and UK Expansion
PremiumCompany Announcements
Avricore Health Shifts Focus to UK Market
PremiumCompany Announcements
Avricore Health Reports Soaring Mid-Year Profits
PremiumCompany Announcements
Avricore Health Grants Stock Options and Touts HealthTab™
PremiumCompany Announcements
Avricore Health Boasts Robust Mid-Year FinancialsPremiumCompany Announcements
Avricore Health Achieves First Net ProfitabilityPremiumCompany Announcements
Avricore Health Posts Q1 Profit and Asset GrowthOptions Prices
Currently, No data available
---
Ownership Overview
AVCRF FAQ
What was Avricore Health Inc.’s price range in the past 12 months?
Avricore Health Inc. lowest stock price was $0.03 and its highest was $0.25 in the past 12 months.
What is Avricore Health Inc.’s market cap?
Avricore Health Inc.’s market cap is $4.55M.
When is Avricore Health Inc.’s upcoming earnings report date?
Avricore Health Inc.’s upcoming earnings report date is May 06, 2025 which is in 106 days.
How were Avricore Health Inc.’s earnings last quarter?
Avricore Health Inc. released its earnings results on Nov 29, 2024. The company reported -$0.001 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.001.
Is Avricore Health Inc. overvalued?
According to Wall Street analysts Avricore Health Inc.’s price is currently Overvalued.
Does Avricore Health Inc. pay dividends?
Avricore Health Inc. does not currently pay dividends.
What is Avricore Health Inc.’s EPS estimate?
Avricore Health Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Avricore Health Inc. have?
Avricore Health Inc. has 101,289,665 shares outstanding.
What happened to Avricore Health Inc.’s price movement after its last earnings report?
Avricore Health Inc. reported an EPS of -$0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Avricore Health Inc.?
Currently, no hedge funds are holding shares in AVCRF
---
Company Description
Avricore Health Inc.
Avricore Health, Inc. engages in the manufacture and distribution of generic and over-the-counter (OTC) pharmaceutical products. It firm operates through the Products and Point of Care business division. The Products business division offers OTC pharmaceutical through its Corozon platform. The Point of Care business division provides point of care screening services through its HealthTab system and software platform. Its products include Hema-fer, Cortivera, and Sennace. The company was founded on May 30, 2000 and is headquartered in Vancouver, Canada.
---
Technical Analysis
BioNano Genomics
―
Can-Fite BioPharma
―
InMed Pharmaceuticals
―
180 Life Sciences
―
Aethlon Medical
―
GlaxoSmithKline
―
---